Log in
Enquire now
Cue Biopharma

Cue Biopharma

Cue Biopharma is a company founded in 2014 by Ronald D. Seidel III, Steven Almo, Rodolfo J. Chaparro and Dan Passeri.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
0
Board of Directors
‌
Aaron Fletcher
0
‌
Dan Passeri
0
‌
Frank Morich
0
‌
Fred Driscoll
0
‌
Tamar Howson
0
Peter Kiener
Peter Kiener
0
CEO
‌
Dan Passeri
0
CIK Number
1,645,460
0
Legal Name
Cue Biopharma, Inc.
Company Operating Status
Active
Country
United States
United States
0
Crunchbase URL
crunchbase.com/organiz...iopharma
Email Address
0
Founded Date
2014
0
Founder
‌
Dan Passeri
0
‌
Rodolfo J. Chaparro
0
‌
Ronald D. Seidel III
0
‌
Steven Almo
0
Full Address
40 Guest Street Boston, MA 02135, USA
0
Industry
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Healthcare
Healthcare
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Immunotherapy
Immunotherapy
IRS Number
473,324,577
0
Latest Funding Round Date
January 24, 2017
LinkedIn URL
@company/cuebiopharma
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
Boston
Boston
0
NAICS Code
325,412
0
Number of Employees (Ranges)
11 – 50
0
Patents Assigned (Count)
4
Phone Number
0
Pitchbook URL
pitchbook.com/profiles...169173-82
Place of Incorporation
Delaware
Delaware
0
Previous Name
Imagen Biopharma, Inc.
0
SIC Code
2,834
0
Exchange
Nasdaq
Nasdaq
0
Stock Symbol
CUE
0
Ticker Symbol
CUE
Total Funding Amount (USD)
26,000,000
Twitter URL
@cuebiopharma
Official Website
cuebiopharma.com
YouTube Channel
youtube.com/channel/U...DNiU4n27JA

Find more companies like Cue Biopharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.